A propensity-matched analysis comparing survival after primary minimally invasive esophagectomy followed by adjuvant therapy to neoadjuvant therapy for esophagogastric adenocarcinoma

被引:17
作者
Zahoor, Haris [1 ]
Luketich, James D. [2 ]
Levy, Ryan M. [2 ]
Awais, Omar [2 ]
Winger, Daniel G. [3 ]
Gibson, Michael K. [4 ]
Nason, Katie S. [2 ]
机构
[1] Univ Pittsburgh, Dept Med, Pittsburgh, PA USA
[2] Univ Pittsburgh, Dept Cardiothorac Surg, Pittsburgh, PA USA
[3] Univ Pittsburgh, Translat Sci Inst, Pittsburgh, PA USA
[4] Case Western Reserve Univ, Dept Med, Cleveland, OH 44106 USA
关键词
RANDOMIZED CONTROLLED-TRIALS; DISEASE-FREE SURVIVAL; PREOPERATIVE CHEMORADIATION; ENDOSCOPIC ULTRASOUND; COMPLETE RESPONSE; SURGERY; CANCER; CHEMOTHERAPY; CHEMORADIOTHERAPY; OUTCOMES;
D O I
10.1016/j.jtcvs.2014.10.044
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives: Prognosis for patients with locally advanced esophagogastric adenocarcinoma (EAC) is poor with surgery alone, and adjuvant therapy after open esophagectomy is frequently not tolerated. After minimally invasive esophagectomy (MIE); however, earlier return to normal function may render patients better able to receive adjuvant therapy. We examined whether primary MIE followed by adjuvant chemotherapy influenced survival compared with propensity-matched patients treated with neoadjuvant therapy. Methods: Patients with stage II or higher EAC treated with MIE (N = 375) were identified. Using 30 pretreatment covariates, propensity for assignment to either neoadjuvant followed by MIE (n = 183; 54%) or MIE as primary therapy (n = 156; 46%) was calculated, generating 97 closely matched pairs. Hazard ratios were adjusted for age, sex, body mass index, smoking, comorbidity, and final pathologic stage. Results: In propensity-matched pairs, adjusted hazard ratio for death did not differ significantly for primary MIE compared with neoadjuvant (hazard ratio, 0.83; 95% confidence interval, 0.60-1.16). Recurrence patterns were similar between groups and 65% of patients with IIb or greater pathologic stage received adjuvant therapy. Clinical staging was inaccurate in 37 out of 105 patients (35%) who underwent primary MIE (n = 18 upstaged and n = 19 downstaged). Conclusions: Primary MIE followed by adjuvant chemotherapy guided by pathologic findings did not negatively influence survival and allowed for accurate staging compared with clinical staging. Our data suggest that primary MIE in patients with resectable EAC may be a reasonable approach, improving stage-based prognostication and potentially minimizing overtreatment in patients with early stage disease through accurate stage assignments. A randomized controlled trial testing this hypothesis is needed.
引用
收藏
页码:538 / 547
页数:10
相关论文
共 48 条
[21]   Minimally invasive surgical staging for esophageal cancer [J].
Luketich, JD ;
Meehan, M ;
Nguyen, NT ;
Christie, N ;
Weigel, T ;
Yousem, S ;
Keenan, RJ ;
Schauer, PR .
SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES, 2000, 14 (08) :700-702
[22]   Does FDG-PET Add Information to EUS and CT in the Initial Management of Esophageal Cancer? A Prospective Single Center Study [J].
McDonough, Patrick B. ;
Jones, David R. ;
Shen, K. R. ;
Northup, Patrick G. ;
Galysh, Roman L. ;
Hernandez, Alfredo ;
White, Grace E. ;
Kahaleh, Michel ;
Shami, Vanessa M. .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2008, 103 (03) :570-574
[23]   CONSTRUCTION AND VALIDATION OF AN ALTERNATE FORM GENERAL MENTAL-HEALTH SCALE FOR THE MEDICAL OUTCOMES STUDY SHORT-FORM 36-ITEM HEALTH SURVEY [J].
MCHORNEY, CA ;
WARE, JE .
MEDICAL CARE, 1995, 33 (01) :15-28
[24]   Improved Outcomes in the Management of Esophageal Cancer with the Addition of Surgical Resection to Chemoradiation Therapy [J].
McKenzie, Shaun ;
Mailey, Brian ;
Artinyan, Avo ;
Metchikian, Michelle ;
Shibata, Stephen ;
Kernstine, Kemp ;
Kim, Joseph .
ANNALS OF SURGICAL ONCOLOGY, 2011, 18 (02) :551-558
[25]   Recurrence after neoadjuvant chemoradiation and surgery for esophageal cancer: Does the pattern of recurrence differ for patients with complete response and those with partial or no response? [J].
Meguid, Robert A. ;
Hooker, Craig M. ;
Taylor, Joshua T. ;
Kleinberg, Laurence R. ;
Cattaneo, Stephen M., II ;
Sussman, Marc S. ;
Yang, Stephen C. ;
Heitmiller, Richard F. ;
Forastiere, Arlene A. ;
Brock, Malcolm V. .
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2009, 138 (06) :1309-1317
[26]  
Page D.L., 2002, AJCC Cancer Staging Manual, V6th
[27]   Assessment and Comparison of Recovery after Open and Minimally Invasive Esophagectomy for Cancer: An Exploratory Study in Two Centers [J].
Parameswaran, R. ;
Titcomb, D. R. ;
Blencowe, N. S. ;
Berrisford, R. G. ;
Wajed, S. A. ;
Streets, C. G. ;
Hollowood, A. D. ;
Krysztopik, R. ;
Barham, C. P. ;
Blazeby, J. M. .
ANNALS OF SURGICAL ONCOLOGY, 2013, 20 (06) :1970-1977
[28]   Technique of Minimally Invasive Ivor Lewis Esophagectomy [J].
Pennathur, Arjun ;
Awais, Omar ;
Luketich, James D. .
ANNALS OF THORACIC SURGERY, 2010, 89 (06) :S2159-S2162
[29]   THE CENTRAL ROLE OF THE PROPENSITY SCORE IN OBSERVATIONAL STUDIES FOR CAUSAL EFFECTS [J].
ROSENBAUM, PR ;
RUBIN, DB .
BIOMETRIKA, 1983, 70 (01) :41-55
[30]   Histomorphologic tumor regression and lymph node metastases determine prognosis following neoadjuvant radiochemotherapy for esophageal cancer - implications for response classification [J].
Schneider, PM ;
Baldus, SE ;
Metzger, R ;
Kocher, M ;
Bongartz, R ;
Bollschweiler, E ;
Schaefer, H ;
Thiele, J ;
Dienes, HP ;
Mueller, RP ;
Hoelscher, AH .
ANNALS OF SURGERY, 2005, 242 (05) :684-692